GoodRx Holdings, Inc. (NASDAQ:GDRX) was among the stocks on Jim Cramer’s radar as he highlighted the importance of lower interest rates in sustaining the broader market rally. When a caller mentioned ...
The average one-year price target for GoodRx Holdings (NasdaqGS:GDRX) has been revised to $3.17 / share. This is an increase ...
GoodRx (NASDAQ:GDRX) reported first-quarter 2026 results that management said showed “continued momentum across our strategic ...
Quarterly filings reveal markedly different revenue trajectories and margin profiles for these two healthcare platforms. What ...
Guidance changed upward: Q4 2025 guidance was “$750 million to $780 million” revenue and “at least $230 million” adjusted EBITDA, while Q1 2026 guidance moved to “$765 million to $785 million” and “at ...
Shares of healthcare tech company GoodRx (NASDAQ:GDRX) jumped 9.5% in the afternoon session after it announced it would ...
Year in the First Quarter Company Raises Full Year 2026 Revenue and Adjusted EBITDA ExpectationsSANTA MONICA, ...
MedPage Today on MSN
Trump Promised Cheaper Drugs. Some Prices Dropped. Many Others Shot Up.
Biggest win for patients has likely been the continuation of Medicare drug price negotiati ...
Amazon Pharmacy is expanding access to Ozempic pills for type 2 diabetes through same day delivery and kiosk pickups across thousands of US locations. The move broadens digital and retail pharmacy ...
Detailed price information for Goodrx Holdings Inc Cl A (GDRX-Q) from The Globe and Mail including charting and trades.
GoodRx (GDRX) announced that it has become a major integration partner for Pfizer (PFE) and other pharmaceutical companies, which offer discounts on TrumpRx, a newly launched government website ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results